Monte Rosa Therapeutics GLUE - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Monte Rosa Therapeutics Inc (GLUE)
Monte Rosa Therapeutics Inc (GLUE) Options

Monte Rosa Therapeutics Inc (GLUE)

5.89

-0.14

( -2.32% )

Updated: 01:09:38

Delayed by 15 minutes

GLUE Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	1.45	5.70	0.00	3.575	0.00	0.00 %	0	0	-
5.00	0.65	3.90	0.00	2.275	0.00	0.00 %	0	0	-
7.50	0.40	0.95	0.40	0.675	0.00	0.00 %	0	42	-

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.05	0.05	0.05	0.05	0.00	0.00 %	0	10	-
5.00	0.05	1.05	0.15	0.55	0.00	0.00 %	0	12	-
7.50	1.15	2.35	2.00	1.75	0.00	0.00 %	0	4	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SYRSSyros Pharmaceuticals Inc	US$ 0.2359 (157.53%)	307.14M
TSVT2seventy bio Inc	US$ 4.925 (75.89%)	20.15M
RAYRaytech Holding Ltd	US$ 1.37 (57.47%)	1.03M
CUTRCutera Inc	US$ 0.1989 (54.79%)	114.66M
AWHAspira Womans Health Inc	US$ 0.2718 (37.27%)	144.12M
ARVNArvinas Inc	US$ 8.74 (-50.23%)	4.48M
LZMHLZ Technology Holdings Ltd	US$ 8.99 (-42.59%)	69.63k
SPGCSacks Parente Golf Inc	US$ 0.1058 (-33.92%)	17.85M
BDRXBiodexa Pharmaceuticals PLC	US$ 2.22 (-22.11%)	307.52k
STSSSharps Technology Inc	US$ 0.3452 (-21.55%)	8.24M
SYRSSyros Pharmaceuticals Inc	US$ 0.2359 (157.53%)	307.14M
AWHAspira Womans Health Inc	US$ 0.2718 (37.27%)	144.12M
CUTRCutera Inc	US$ 0.1989 (54.79%)	114.66M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 7.795 (5.62%)	97.1M
NVDANVIDIA Corporation	US$ 108.175 (1.12%)	69.25M

Monksdream

Monksdream 3 months ago

corncakes0

corncakes0 4 months ago

Woodpecker3

Woodpecker3 4 months ago

$GLUE investors have been in what Cramer calls "the house of pain" for months. Many purchased this at $40,$50,$60,$70 per share. The company will be added to the long list of biotech failures once the inevitable FDA trial failure is confirmed.

Woodpecker3

Woodpecker3 4 months ago

$GLUE will soon be added to this list

https://www.fiercebiotech.com/special-reports/2023s-top-10-clinical-trial-flops

Woodpecker3

Woodpecker3 4 months ago

$GLUE trapped alot of "investors" earlier this week at 10+ all the way to 12.50/Share. It is cratering just as precipitously. Watch for less than 8....7.....6... in days to come.

Woodpecker3

Woodpecker3 4 months ago

$GLUE - No products. no revenues, massive losses, running out of cash. Millions of shares avaiable to short. Looking for $5/share

Monksdream

Monksdream 6 months ago

Monksdream

Monksdream 6 months ago

Monksdream

Monksdream 7 months ago

Monksdream

Monksdream 8 months ago

Monte Rosa Therapeutics

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions